Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2026-01-06 @ 6:25 AM
Study NCT ID:
NCT03275402
Status:
TERMINATED
Last Update Posted:
2024-02-13
First Post:
2017-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Sponsor:
Y-mAbs Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-06
First Submit QC Date:
None
Study First Post Date:
2017-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-18
Results First Submit QC Date:
None
Results First Post Date:
2024-02-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-22
Last Update Post Date:
2024-02-13
Last Update Post Date Type:
ACTUAL